Avanafil 13C5 15N
| Product Name | Avanafil 13C5 15N |
|---|---|
| Alternate Names | Avanafil Stable Isotopes, Stable Isotopes of Avanafil |
| CAT No. | CS-O-15725 |
| CAS No. | 330784-47-9(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 489.91 g/mol |
| Mol. For. | C₁₈[¹³C]₅H₂₆ClN₆[¹⁵N]O₃ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Avanafil |
| Purity | >98 |
| Therapeutic | Erectile dysfunction |
| Smileys | O[13C]([13C@H]([13CH2][13CH2][13CH2]1)[15N]1C2=NC=C(C(NCC3=NC=CC=N3)=O)C(NCC4=CC(Cl)=C(OC)C=C4)=N2)([2H])[2H] |
| Canonical Smiles | COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCCC4CO)Cl |
| InchIKey | WEAJZXNPAWBCOA-INIZCTEOSA-N |
| Inchl | InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 |
| IUPAC | 4-[(3-chloro-4-methoxyphenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Avanafil 13C5 15N is a chemical compound that belongs to the class of phosphodiesterase type 5 (PDE5) inhibitors. It is used in the treatment of erectile dysfunction (ED) in men. It works by increasing blood flow to the penis, which helps in achieving and maintaining an erection during sexual activity. Avanafil 13C5 15N is a more potent and selective inhibitor of PDE5 compared to other drugs in the same class, such as sildenafil and tadalafil.
Chemically, Avanafil 13C5 15N is a synthetic derivative of pyrimidine, and it is structurally similar to other PDE5 inhibitors. It is labeled with isotopes of carbon and nitrogen, which are used in research and development studies to track the metabolism and pharmacokinetics of the drug.
Avanafil 13C5 15N is administered orally, and it is rapidly absorbed from the gastrointestinal tract. The drug has a half-life of approximately 5 hours, and it is metabolized mainly in the liver. The metabolites of Avanafil 13C5 15N are excreted in the urine and feces.
In conclusion, Avanafil 13C5 15N is a potent and selective PDE5 inhibitor that is used in the treatment of ED. It is a chemically labeled compound that is used in research studies to track the metabolism and pharmacokinetics of the drug. Avanafil 13C5 15N is administered orally, and it is rapidly absorbed from the gastrointestinal tract, with a half-life of approximately 5 hours.
Get an Instant Quote
Related Compounds
Avanafil D4 | Avanafil 13C5 | Avanafil 13C5 15N D2 | Avanafil-13C d5 | Avanafil-13C-d3 | Avanafil-d5 |